Breaking News, Financial News

Lonza

Custom manufacturing revenues drop.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza 2Q10

YTD Revenues: $1.2 billion (+9%)

YTD Earnings: $125 million (+19%)

Comments: Revenues at the Custom Manufacturing unit fell 3% to $609 million due to low utilization in two facilities. Biological manufacturing increased utilization, with several new products coming online, but the company did not provide breakouts of that business.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters